FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039450 [Registered on: 14/01/2022] Trial Registered Prospectively
Last Modified On: 14/01/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Letrozole alone with Letrozole and HCG on pregnancy rates in PCOS women with anovulatory infertility : A randomised controlled trial 
Scientific Title of Study   Comparison of Letrozole alone with Letrozole and HCG on pregnancy rate in pcos women with anovulatory infertility : A randomised controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Neeraj 
Designation  Post Graduate 
Affiliation  LHMC 
Address  Gynaecology OPD room no 12 LHMC
Gynaecology office New building ground floor
Central
DELHI
110001
India 
Phone  9654072706  
Fax    
Email  neerajjindal62211@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Manju Puri 
Designation  Director professor 
Affiliation  LHMC 
Address  Gynaecology OPD Room no 12 LHMC

Central
DELHI
110001
India 
Phone  9654072706  
Fax    
Email  drmanjupuri@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Neeraj 
Designation  Post Graduate 
Affiliation  LHMC 
Address  Room no 208 RMO A hostel LHMC

Central
DELHI
110001
India 
Phone  9654072706  
Fax    
Email  neerajjindal62211@gmail.com  
 
Source of Monetary or Material Support  
Lady Hardinge Medical College ,DIZ area, Connaught place, New Delhi 
 
Primary Sponsor  
Name  Lady Hardinge Medical college 
Address  Shaheed Bhagat Singh Marg , DIZ area, Connaught Place, New Delhi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Neeraj  Lady Hardinge Medical College  OPD Room 12 Obstetrics and Gynaecology , LHMC
Central
DELHI 
9654072706

neerajjindal62211@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Lady Hardinge Medical College and Associated Hospitals , New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N970||Female infertility associated withanovulation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Letrozole   Tablet letrozole two and half mg from day 3 of menses for 5 days 
Intervention  Letrozole and HCG Injection HCG five thousand IU im given when follicle diameter reached more than 18mm along with tab Letrozole  Injection HCG five thousand IU im given when follicle diameter reached more than 18mm along with tab Letrozole. it will be studied for 3 cycles. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Anovulatory Infertile PCOS women in age group 20 -35 years. 
 
ExclusionCriteria 
Details  S.FSH levels > 10 IU/L
Other associated causes of female infertilty such as tubal factor or male factor
Women with history of ovarian surgery , ovarian tumor , pelvic adhesions or endometriosis. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Proportion of women with positive urinary pregnancy test in each group when they are overdue by 1 week from expected date of menses  when they are overdue by 1 week from expected date of menses 
 
Secondary Outcome  
Outcome  TimePoints 
Proportion of women with USG documented live pregnancy in each group after two weeks overdue from expected date of menses.
Comparison of mean duration of luteal phase in both groups.
Comparison of D21 mean serum progesterone levels in both groups.
 
Not applicable as it will depend on when the patient is getting periods 
 
Target Sample Size   Total Sample Size="75"
Sample Size from India="75" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Comparison of letrozole alone with letrozole and HCG on pregnancy rates in PCOS women with anovulatory infertility : A randomised controlled trial
Sample size : 75 divided in two groups
one group was given T. letrozole two and half mg and other was given injection HCG 5000 IU im with T.Letrozole
T. Letrozole was given as two and half mg starting from  day 3 of menses for 5 days and injection HCG was given to other group when follicle diameter reached more thanor equal to 18mm.

 
Close